SEARCH

SEARCH BY CITATION

References

  • Adami A., Rossato G., Cerini R., Thijs V. N., Pozzi-Mucelli R., Anzola G. P., Del S. M., Finocchi C., Meneghetti G. and Zanferrari C. (2008) Right-to-left shunt does not increase white matter lesion load in migraine with aura patients. Neurology 71, 101107.
  • Adams M. M., Shi L., Linville M. C. et al. (2008) Caloric restriction and age affect synaptic proteins in hippocampal CA3 and spatial learning ability. Exp. Neurol. 211, 141149.
  • Adelman R., Saul R. L. and Ames B. N. (1988) Oxidative damage to DNA: relation to species metabolic rate and life span. Proc. Natl Acad. Sci. USA 85, 27062708.
  • Aguero-Torres H., Kivipelto M. and von S. E. (2006) Rethinking the dementia diagnoses in a population-based study: what is Alzheimer’s disease and what is vascular dementia? A study from the kungsholmen project. Dement. Geriatr. Cogn. Disord. 22, 244249.
  • Ahima R. S. and Osei S. Y. (2008) Adipokines in obesity. Front. Horm. Res. 36, 182197.
  • Ahren B. and Pacini G. (1998) Age-related reduction in glucose elimination is accompanied by reduced glucose effectiveness and increased hepatic insulin extraction in man. J. Clin. Endocrinol. Metab. 83, 33503356.
  • Akomolafe A., Beiser A., Meigs J. B., Au R., Green R. C., Farrer L. A., Wolf P. A. and Seshadri S. (2006) Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch. Neurol. 63, 15511555.
  • d’Alessio P. (2004) Aging and the endothelium. Exp. Gerontol. 39, 165171.
  • Antuna-Puente B., Feve B., Fellahi S. and Bastard J. P. (2008) Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 34, 211.
  • Arribas S. M., Gordon J. F., Daly C. J., Dominiczak A. F. and McGrath J. C. (1996) Confocal microscopic characterization of a lesion in a cerebral vessel of the stroke-prone spontaneously hypertensive rat. Stroke 27, 11181122.
  • Arvanitakis Z., Wilson R. S., Bienias J. L., Evans D. A. and Bennett D. A. (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch. Neurol. 61, 661666.
  • Arvanitakis Z., Schneider J. A., Wilson R. S., Li Y., Arnold S. E., Wang Z. and Bennett D. A. (2006) Diabetes is related to cerebral infarction but not to AD pathology in older persons. Neurology 67, 19601965.
  • Astrup A., Dyerberg J., Selleck M. and Stender S. (2008) Nutrition transition and its relationship to the development of obesity and related chronic diseases. Obes. Rev. 9(Suppl 1), 4852.
  • Bannon M. J. and Whitty C. J. (1997) Age-related and regional differences in dopamine transporter mRNA expression in human midbrain. Neurology 48, 969977.
  • Baran S. E., Campbell A. M., Kleen J. K., Foltz C. H., Wright R. L., Diamond D. M. and Conrad C. D. (2005) Combination of high fat diet and chronic stress retracts hippocampal dendrites. Neuroreport 16, 3943.
  • Barber R., Scheltens P., Gholkar A., Ballard C., McKeith I., Ince P., Perry R. and O’Brien J. (1999) White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging. J. Neurol. Neurosurg. Psychiatry 67, 6672.
  • Bartus R. T., Dean R. L. III, Beer B. and Lippa A. S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408414.
  • Barzilai N., She L., Liu B. Q., Vuguin P., Cohen P., Wang J. and Rossetti L. (1999) Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes 48, 9498.
  • Baumbach G. L. and Heistad D. D. (1988) Cerebral circulation in chronic arterial hypertension. Hypertension 12, 8995.
  • Baumbach G. L. and Heistad D. D. (1989) Remodeling of cerebral arterioles in chronic hypertension. Hypertension 13, 968972.
  • Baumbach G. L., Dobrin P. B., Hart M. N. and Heistad D. D. (1988) Mechanics of cerebral arterioles in hypertensive rats. Circ. Res. 62, 5664.
  • Behrendt D. and Ganz P. (2002) Endothelial function. From vascular biology to clinical applications. Am. J. Cardiol. 90, 40L48L.
  • Bellinger F. P., Madamba S. G., Campbell I. L. and Siggins G. R. (1995) Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6. Neurosci. Lett. 198, 9598.
  • Berlett B. S. and Stadtman E. R. (1997) Protein oxidation in aging, disease, and oxidative stress. J. Biol. Chem. 272, 2031320316.
  • Bertoni-Freddari C., Fattoretti P., Casoli T., Meier-Ruge W. and Ulrich J. (1990) Morphological adaptive response of the synaptic junctional zones in the human dentate gyrus during aging and Alzheimer’s disease. Brain Res. 517, 6975.
  • Bertoni-Freddari C., Fattoretti P., Pieroni M., Meier-Ruge W. and Ulrich J. (1992) Enlargement of synaptic size as a compensative reaction in aging and dementia. Pathol. Res. Pract. 188, 612615.
  • Bertoni-Freddari C., Fattoretti P., Paoloni R., Caselli U., Galeazzi L. and Meier-Ruge W. (1996) Synaptic structural dynamics and aging. Gerontology 42, 170180.
  • Bertoni-Freddari C., Mocchegiani E., Malavolta M., Casoli T., Di S. G. and Fattoretti P. (2006) Synaptic and mitochondrial physiopathologic changes in the aging nervous system and the role of zinc ion homeostasis. Mech. Ageing Dev. 127, 590596.
  • Bjorntorp P. (1990) “Portal” adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 10, 493496.
  • Blander G. and Guarente L. (2004) The Sir2 family of protein deacetylases. Annu. Rev. Biochem. 73, 417435.
  • Boden G., Chen X., Desantis R. A. and Kendrick Z. (1993) Effects of age and body fat on insulin resistance in healthy men. Diabetes Care 16, 728733.
  • Bolton S. J. and Perry V. H. (1998) Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats. Exp. Neurol. 154, 231240.
  • Bordone L. and Guarente L. (2005) Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat. Rev. Mol. Cell Biol. 6, 298305.
  • Bordone L., Motta M. C., Picard F. et al. (2006) Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol. 4, e31.
  • Brandes R. P., Fleming I. and Busse R. (2005) Endothelial aging. Cardiovasc. Res. 66, 286294.
  • Braun C. A. and Anderson C. M. (2006) Pathophysiology: Functional Alterations in Human Health. Lippincott Williams & Wilkins, Philadelphia.
  • Bravo E., Rivabene R., Bruscalupi G., Calcabrini A., Arancia G. and Cantafora A. (1996) Age-related changes in lipid secretion of perfused livers from male Wistar rats donors. J. Biochem. 119, 240245.
  • Broughton D. L., James O. W., Alberti K. G. and Taylor R. (1991) Peripheral and hepatic insulin sensitivity in healthy elderly human subjects. Eur. J. Clin. Invest. 21, 1321.
  • Bruce-Keller A. J., White C. L., Gupta S., Knight A. G., Pistell P. J., Ingram D. K., Morrison C. D. and Keller J. N. (2010) NOX activity in brain aging: Exacerbation by high fat diet. Free Radic. Biol. Med. 49, 2230.
  • Buettner R., Scholmerich J. and Bollheimer L. C. (2007) High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver. Spring) 15, 798808.
  • Bugalho P., Viana-Baptista M., Jordao C., Secca M. F. and Ferro J. M. (2007) Age-related white matter lesions are associated with reduction of the apparent diffusion coefficient in the cerebellum. Eur. J. Neurol. 14, 10631066.
  • Bullo M., Casas-Agustench P., Amigo-Correig P., Aranceta J. and Salas-Salvado J. (2007) Inflammation, obesity and comorbidities: the role of diet. Public Health Nutr. 10, 11641172.
  • Cai Q., Tian L. and Wei H. (1996) Age-dependent increase of indigenous DNA adducts in rat brain is associated with a lipid peroxidation product. Exp. Gerontol. 31, 373385.
  • Calabrese V., Bates T. E. and Stella A. M. (2000) NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance. Neurochem. Res. 25, 13151341.
  • Calabrese V., Butterfield D. A. and Stella A. M. (2003) Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: novel targets for neuroprotection in Alzheimer’s disease. Ital. J. Biochem. 52, 177181.
  • Calabrese V., Stella A. M., Butterfield D. A. and Scapagnini G. (2004) Redox regulation in neurodegeneration and longevity: role of the heme oxygenase and HSP70 systems in brain stress tolerance. Antioxid. Redox Signal. 6, 895913.
  • Calabrese V., Guagliano E., Sapienza M., Mancuso C., Butterfield D. A. and Stella A. M. (2006) Redox regulation of cellular stress response in neurodegenerative disorders. Ital. J. Biochem. 55, 263282.
  • Calabrese V., Cornelius C., Mancuso C., Lentile R., Stella A. M. and Butterfield D. A. (2010) Redox homeostasis and cellular stress response in aging and neurodegeneration. Methods Mol. Biol. 610, 285308.
  • Carlsson A. (1987) Brain neurotransmitters in aging and dementia: similar changes across diagnostic dementia groups. Gerontology 33, 159167.
  • Carr D. B., Utzschneider K. M., Hull R. L., Kodama K., Retzlaff B. M., Brunzell J. D., Shofer J. B., Fish B. E., Knopp R. H. and Kahn S. E. (2004) Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53, 20872094.
  • Cecarini V., Gee J., Fioretti E., Amici M., Angeletti M., Eleuteri A. M. and Keller J. N. (2007) Protein oxidation and cellular homeostasis: Emphasis on metabolism. Biochim. Biophys. Acta 1773, 93104.
  • Cefalu W. T. (2001) Insulin resistance: cellular and clinical concepts. Exp. Biol. Med. (Maywood) 226, 1326.
  • Cefalu W. T., Wang Z. Q., Werbel S., Bell-Farrow A., Crouse J. R. III, Hinson W. H., Terry J. G. and Anderson R. (1995) Contribution of visceral fat mass to the insulin resistance of aging. Metabolism 44, 954959.
  • Chen M., Bergman R. N., Pacini G. and Porte D. Jr (1985) Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J. Clin. Endocrinol. Metab. 60, 1320.
  • Chen D., Steele A. D., Lindquist S. and Guarente L. (2005) Increase in activity during calorie restriction requires Sirt1. Science 310, 1641.
  • Chen B., Liao W. Q., Xu N., Xu H., Wen J. Y., Yu C. A., Liu X. Y., Li C. L., Zhao S. M. and Campbell W. (2009) Adiponectin protects against cerebral ischemia-reperfusion injury through anti-inflammatory action. Brain Res. 1273, 129137.
  • Clark A. S., Magnusson K. R. and Cotman C. W. (1992) In vitro autoradiography of hippocampal excitatory amino acid binding in aged Fischer 344 rats: relationship to performance on the Morris water maze. Behav. Neurosci. 106, 324335.
  • Clayton D. A. and Browning M. D. (2001) Deficits in the expression of the NR2B subunit in the hippocampus of aged Fisher 344 rats. Neurobiol. Aging 22, 165168.
  • Clayton D. A., Mesches M. H., Alvarez E., Bickford P. C. and Browning M. D. (2002) A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat. J. Neurosci. 22, 36283637.
  • Comfort A. (1964) Ageing: The Biology of Senescence. Routledge & Kegan Paul, London.
  • Coon P. J., Rogus E. M., Drinkwater D., Muller D. C. and Goldberg A. P. (1992) Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J. Clin. Endocrinol. Metab. 75, 11251132.
  • Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689695.
  • Coyle J. T., Bird S. J., Evans R. H., Gulley R. L., Nadler J. V., Nicklas W. J. and Olney J. W. (1981) Excitatory amino acid neurotoxins: selectivity, specificity, and mechanisms of action. Based on an NRP one-day conference held June 30, 1980. Neurosci. Res. Program. Bull. 19, 1427.
  • Craft S. (2005) Insulin resistance syndrome and Alzheimer’s disease: age- and obesity-related effects on memory, amyloid, and inflammation. Neurobiol. Aging 26(Suppl 1), 6569.
  • Craft S., Peskind E., Schwartz M. W., Schellenberg G. D., Raskind M. and Porte D. Jr (1998) Cerebrospinal fluid and plasma insulin levels in Alzheimer’s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology 50, 164168.
  • Curb J. D., Rodriguez B. L., Abbott R. D. et al. (1999) Longitudinal association of vascular and Alzheimer’s dementias, diabetes, and glucose tolerance. Neurology 52, 971975.
  • Damjanovic M. and Barton M. (2008) Fat intake and cardiovascular response. Curr. Hypertens. Rep. 10, 2531.
  • De Feo P., Volpi E., Lucidi P., Cruciani G., Reboldi G., Siepi D., Mannarino E., Santeusanio F., Brunetti P. and Bolli G. B. (1993) Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes 42, 9951002.
  • Dechenes C. J., Verchere C. B., Andrikopoulos S. and Kahn S. E. (1998) Human aging is associated with parallel reductions in insulin and amylin release. Am. J. Physiol. 275, E785E791.
  • DeFronzo R. A. (1979) Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 28, 10951101.
  • DeFronzo R. A. (1981) Glucose intolerance and aging. Diabetes Care 4, 493501.
  • DeKosky S. T. and Scheff S. W. (1990) Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity. Ann. Neurol. 27, 457464.
  • Desai A., Grolleau-Julius A. and Yung R. (2010) Leukocyte function in the aging immune system. J. Leukoc. Biol. in press.
  • Ding Q., Dimayuga E. and Keller J. N. (2006) Proteasome regulation of oxidative stress in aging and age-related diseases of the CNS. Antioxid. Redox Signal. 8, 163172.
  • Diniz Y. S., Rocha K. K., Souza G. A., Galhardi C. M., Ebaid G. M., Rodrigues H. G., Novelli Filho J. L., Cicogna A. C. and Novelli E. L. (2006) Effects of N-acetylcysteine on sucrose-rich diet-induced hyperglycaemia, dyslipidemia and oxidative stress in rats. Eur. J. Pharmacol. 543, 151157.
  • Droge W. and Schipper H. M. (2007) Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6, 361370.
  • Dunn W. R., Wallis S. J. and Gardiner S. M. (1998) Remodelling and enhanced myogenic tone in cerebral resistance arteries isolated from genetically hypertensive Brattleboro rats. J. Vasc. Res. 35, 1826.
  • Eckles-Smith K., Clayton D., Bickford P. and Browning M. D. (2000) Caloric restriction prevents age-related deficits in LTP and in NMDA receptor expression. Brain Res. Mol. Brain Res. 78, 154162.
  • Elahi D., Muller D. C., Egan J. M., Andres R., Veldhuist J. and Meneilly G. S. (2002) Glucose tolerance, glucose utilization and insulin secretion in ageing. Novartis Found. Symp. 242, 222242.
  • Elias P. K., Elias M. F., D’Agostino R. B., Cupples L. A., Wilson P. W., Silbershatz H. and Wolf P. A. (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. The Framingham Study. Diabetes Care 20, 13881395.
  • Elias M. F., Elias P. K., Sullivan L. M., Wolf P. A. and D’Agostino R. B. (2003) Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int. J. Obes. Relat. Metab. Disord. 27, 260268.
  • Elias M. F., Elias P. K., Sullivan L. M., Wolf P. A. and D’Agostino R. B. (2005) Obesity, diabetes and cognitive deficit: The Framingham Heart Study. Neurobiol. Aging 26(Suppl 1), 1116.
  • van Exel E., de Craen A. J., Gussekloo J., Houx P., Bootsma-van der Wiel A., Macfarlane P. W., Blauw G. J. and Westendorp R. G. (2002) Association between high-density lipoprotein and cognitive impairment in the oldest old. Ann. Neurol. 51, 716721.
  • Fagot-Campagna A., Balkau B., Simon D., Warnet J. M., Claude J. R., Ducimetiere P. and Eschwege E. (1998) High free fatty acid concentration: an independent risk factor for hypertension in the Paris Prospective Study. Int. J. Epidemiol. 27, 808813.
  • Fantuzzi G. (2005) Adipose tissue, adipokines, and inflammation. J. Allergy Clin. Immunol. 115, 911919.
  • Farr S. A., Yamada K. A., Butterfield D. A., Abdul H. M., Xu L., Miller N. E., Banks W. A. and Morley J. E. (2008) Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 149, 26282636.
  • Fassbender K., Bertsch T., Mielke O., Muhlhauser F. and Hennerici M. (1999) Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 30, 16471650.
  • Ferrannini E., Barrett E. J., Bevilacqua S. and DeFronzo R. A. (1983) Effect of fatty acids on glucose production and utilization in man. J. Clin. Invest. 72, 17371747.
  • Ferrannini E., Vichi S., Beck-Nielsen H., Laakso M., Paolisso G. and Smith U. (1996) Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes 45, 947953.
  • Ferrannini E., Natali A., Capaldo B., Lehtovirta M., Jacob S. and Yki-Jarvinen H. (1997) Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR). Hypertension 30, 11441149.
  • Festa A., D’Agostino R. Jr, Howard G., Mykkanen L., Tracy R. P. and Haffner S. M. (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102, 4247.
  • Finch C. E. (2005) Developmental origins of aging in brain and blood vessels: an overview. Neurobiol. Aging 26, 281291.
  • Finkel T. and Holbrook N. J. (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408, 239247.
  • Franceschi M., Cecchetto R., Minicucci F., Smizne S., Baio G. and Canal N. (1984) Cognitive processes in insulin-dependent diabetes. Diabetes Care 7, 228231.
  • Freund G. (1980) Cholinergic receptor loss in brains of aging mice. Life Sci. 26, 371375.
  • Fridlyand L. E. and Philipson L. H. (2006) Reactive species, cellular repair and risk factors in the onset of type 2 diabetes mellitus: review and hypothesis. Curr. Diabetes Rev. 2, 241259.
  • Friedman J. M. and Halaas J. L. (1998) Leptin and the regulation of body weight in mammals. Nature 395, 763770.
  • Frohman E. M., Frohman T. C., Gupta S., de F. A. and van den Noort S. (1991) Expression of intercellular adhesion molecule 1 (ICAM-1) in Alzheimer’s disease. J. Neurol. Sci. 106, 105111.
  • Frolich L., Blum-Degen D., Bernstein H. G. et al. (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease. J. Neural. Transm. 105, 423438.
  • Fruhbeck G. (2008) Overview of adipose tissue and its role in obesity and metabolic disorders. Methods Mol. Biol. 456, 122.
  • Fujimoto W. Y., Bergstrom R. W., Boyko E. J., Chen K. W., Leonetti D. L., Newell-Morris L., Shofer J. B. and Wahl P. W. (1999) Visceral adiposity and incident coronary heart disease in Japanese-American men. The 10-year follow-up results of the Seattle Japanese-American Community Diabetes Study. Diabetes Care 22, 18081812.
  • Furukawa S., Fujita T., Shimabukuro M., Iwaki M., Yamada Y., Nakajima Y., Nakayama O., Makishima M., Matsuda M. and Shimomura I. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest. 114, 17521761.
  • Gabbita S. P., Lovell M. A. and Markesbery W. R. (1998) Increased nuclear DNA oxidation in the brain in Alzheimer’s disease. J. Neurochem. 71, 20342040.
  • Gabriely I., Ma X. H., Yang X. M., Atzmon G., Rajala M. W., Berg A. H., Scherer P., Rossetti L. and Barzilai N. (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51, 29512958.
  • Gazzaley A. H., Weiland N. G., McEwen B. S. and Morrison J. H. (1996) Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus. J. Neurosci. 16, 68306838.
  • Gemma C. and Bickford P. C. (2007) Interleukin-1beta and caspase-1: players in the regulation of age-related cognitive dysfunction. Rev. Neurosci. 18, 137148.
  • Gibson G. E. and Peterson C. (1981) Aging decreases oxidative metabolism and the release and synthesis of acetylcholine. J. Neurochem. 37, 978984.
  • Gibson G. E., Peterson C. and Jenden D. J. (1981) Brain acetylcholine synthesis declines with senescence. Science 213, 674676.
  • Giunta S. (2008) Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm- aging, from robustness to frailty. Inflamm. Res. 57, 558563.
  • Gold P. E. (2005) Glucose and age-related changes in memory. Neurobiol. Aging 26(Suppl 1), 6064.
  • Gonzalez J. M., Somoza B., Conde M. V., Fernandez-Alfonso M. S., Gonzalez M. C. and Arribas S. M. (2008) Hypertension increases middle cerebral artery resting tone in spontaneously hypertensive rats: role of tonic vasoactive factor availability. Clin. Sci. (Lond) 114, 651659.
  • Good P. F., Werner P., Hsu A., Olanow C. W. and Perl D. P. (1996) Evidence of neuronal oxidative damage in Alzheimer’s disease. Am. J. Pathol. 149, 2128.
  • Granholm A. C., Bimonte-Nelson H. A., Moore A. B., Nelson M. E., Freeman L. R. and Sambamurti K. (2008) Effects of a saturated fat and high cholesterol diet on memory and hippocampal morphology in the middle-aged rat. J. Alzheimers Dis. 14, 133145.
  • Gray S. G. and Ekstrom T. J. (2001) The human histone deacetylase family. Exp. Cell Res. 262, 7583.
  • Greenwood C. E. and Winocur G. (1990) Learning and memory impairment in rats fed a high saturated fat diet. Behav. Neural. Biol. 53, 7487.
  • Griffin W. S., Sheng J. G., Roberts G. W. and Mrak R. E. (1995) Interleukin-1 expression in different plaque types in Alzheimer’s disease: significance in plaque evolution. J. Neuropathol. Exp. Neurol. 54, 276281.
  • Gunning-Dixon F. M., Brickman A. M., Cheng J. C. and Alexopoulos G. S. (2009) Aging of cerebral white matter: a review of MRI findings. Int. J. Geriatr. Psychiatry 24, 109117.
  • Gupta G., Cases J. A., She L., Ma X. H., Yang X. M., Hu M., Wu J., Rossetti L. and Barzilai N. (2000) Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation. Am. J. Physiol. Endocrinol. Metab. 278, E985E991.
  • Guttmann C. R., Jolesz F. A., Kikinis R., Killiany R. J., Moss M. B., Sandor T. and Albert M. S. (1998) White matter changes with normal aging. Neurology 50, 972978.
  • Haan M. N., Mungas D. M., Gonzalez H. M., Ortiz T. A., Acharya A. and Jagust W. J. (2003) Prevalence of dementia in older latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J. Am. Geriatr. Soc. 51, 169177.
  • Handschin C. and Spiegelman B. M. (2006) Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 27, 728735.
  • Harvey J., Shanley L. J., O’Malley D. and Irving A. J. (2005) Leptin: a potential cognitive enhancer? Biochem. Soc. Trans. 33, 10291032.
  • Haslam D. W. and James W. P. (2005) Obesity. Lancet 366, 11971209.
  • van der Heide L. P., Kamal A., Artola A., Gispen W. H. and Ramakers G. M. (2005) Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner. J. Neurochem. 94, 11581166.
  • Heistad D. D., Mayhan W. G., Coyle P. and Baumbach G. L. (1990) Impaired dilatation of cerebral arterioles in chronic hypertension. Blood Vessels 27, 258262.
  • Heitner J. and Dickson D. (1997) Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects. A retrospective postmortem immunocytochemical and histofluorescent study. Neurology 49, 13061311.
  • Ho L., Qin W., Pompl P. N. et al. (2004) Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. FASEB J. 18, 902904.
  • Hosokawa M. and Ueno M. (1999) Aging of blood-brain barrier and neuronal cells of eye and ear in SAM mice. Neurobiol. Aging 20, 117123.
  • Howard G., Bergman R., Wagenknecht L. E., Haffner S. M., Savage P. J., Saad M. F., Laws A. and D’Agostino R. B. Jr (1998) Ability of alternative indices of insulin sensitivity to predict cardiovascular risk: comparison with the “minimal model” Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Ann. Epidemiol. 8, 358369.
  • Hoyer S. (2004) Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur. J. Pharmacol. 490, 115125.
  • Hsu J. L., Leemans A., Bai C. H., Lee C. H., Tsai Y. F., Chiu H. C. and Chen W. H. (2008) Gender differences and age-related white matter changes of the human brain: a diffusion tensor imaging study. Neuroimage 39, 566577.
  • Hu D., Serrano F., Oury T. D. and Klann E. (2006) Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci. 26, 39333941.
  • Hultsch D. F., Macdonald S. W. and Dixon R. A. (2002) Variability in reaction time performance of younger and older adults. J. Gerontol. B Psychol. Sci. Soc. Sci. 57, 101115.
  • Hynd M. R., Scott H. L. and Dodd P. R. (2004) Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer’s disease. Neurochem. Int. 45, 583595.
  • Iqbal N. (2007) The burden of type 2 diabetes: strategies to prevent or delay onset. Vasc. Health Risk Manag. 3, 511520.
  • Itateyama E., Chiba S., Sakata T. and Yoshimatsu H. (2003) Hypothalamic neuronal histamine in genetically obese animals: its implication of leptin action in the brain. Exp. Biol. Med. (Maywood) 228, 11321137.
  • Iyo M. and Yamasaki T. (1993) The detection of age-related decrease of dopamine D1, D2 and serotonin 5-HT2 receptors in living human brain. Prog. Neuropsychopharmacol. Biol. Psychiatry 17, 415421.
  • Izumi Y., Yamada K. A., Matsukawa M. and Zorumski C. F. (2003) Effects of insulin on long-term potentiation in hippocampal slices from diabetic rats. Diabetologia 46, 10071012.
  • James T. C. and Kanungo M. S. (1976) Alterations in atropine sites of the brain of rats as a function of age. Biochem. Biophys. Res. Commun. 72, 170175.
  • Jankowsky J. L. and Patterson P. H. (1999) Cytokine and growth factor involvement in long-term potentiation. Mol. Cell. Neurosci. 14, 273286.
  • Janson J., Laedtke T., Parisi J. E., O’Brien P., Petersen R. C. and Butler P. C. (2004) Increased risk of type 2 diabetes in Alzheimer disease. Diabetes 53, 474481.
  • Jia J. P., Jia J. M., Zhou W. D., Xu M., Chu C. B., Yan X. and Sun Y. X. (2004) Differential acetylcholine and choline concentrations in the cerebrospinal fluid of patients with Alzheimer’s disease and vascular dementia. Chin. Med. J. (Engl.) 117, 11611164.
  • Joseph J. A., Shukitt-Hale B., Casadesus G. and Fisher D. (2005) Oxidative stress and inflammation in brain aging: nutritional considerations. Neurochem. Res. 30, 927935.
  • Juhan-Vague I., Thompson S. G. and Jespersen J. (1993) Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler. Thromb. 13, 18651873.
  • Kaasinen V., Vilkman H., Hietala J., Nagren K., Helenius H., Olsson H., Farde L. and Rinne J. (2000) Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain. Neurobiol. Aging 21, 683688.
  • Kanoski S. E., Meisel R. L., Mullins A. J. and Davidson T. L. (2007) The effects of energy-rich diets on discrimination reversal learning and on BDNF in the hippocampus and prefrontal cortex of the rat. Behav. Brain Res. 182, 5766.
  • Kennedy K. M. and Raz N. (2009) Pattern of normal age-related regional differences in white matter microstructure is modified by vascular risk. Brain Res. 1297, 4156.
  • Kirwan J. P., Kohrt W. M., Wojta D. M., Bourey R. E. and Holloszy J. O. (1993) Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women. J. Gerontol. 48, M84M90.
  • Kissebah A. H., Alfarsi S., Adams P. W. and Wynn V. (1976) Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in man. Diabetologia 12, 563571.
  • Kitani K., Minami C., Yamamoto T., Maruyama W., Kanai S., Ivy G. O. and Carrillo M. C. (2001) Do antioxidant strategies work against aging and age-associated disorders? Propargylamines: a possible antioxidant strategy. Ann. N Y Acad. Sci. 928, 248260.
  • Klann E. (1998) Cell-permeable scavengers of superoxide prevent long-term potentiation in hippocampal area CA1. J. Neurophysiol. 80, 452457.
  • Klann E., Roberson E. D., Knapp L. T. and Sweatt J. D. (1998) A role for superoxide in protein kinase C activation and induction of long-term potentiation. J. Biol. Chem. 273, 45164522.
  • Knapp L. T. and Klann E. (2002) Role of reactive oxygen species in hippocampal long-term potentiation: contributory or inhibitory? J. Neurosci. Res. 70, 17.
  • Koenig W., Sund M., Frohlich M., Fischer H. G., Lowel H., Doring A., Hutchinson W. L. and Pepys M. B. (1999) C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99, 237242.
  • Kuk J. L., Saunders T. J., Davidson L. E. and Ross R. (2009) Age-related changes in total and regional fat distribution. Ageing Res. Rev. 8, 339348.
  • Kumar M. V., Moore R. L. and Scarpace P. J. (1999) Beta3-adrenergic regulation of leptin, food intake, and adiposity is impaired with age. Pflugers Arch. 438, 681688.
  • Kumari M., Brunner E. and Fuhrer R. (2000) Minireview: mechanisms by which the metabolic syndrome and diabetes impair memory. J. Gerontol. A Biol. Sci. Med. Sci. 55, B228B232.
  • Kuo Y. M., Emmerling M. R., Bisgaier C. L., Essenburg A. D., Lampert H. C., Drumm D. and Roher A. E. (1998) Elevated low-density lipoprotein in Alzheimer’s disease correlates with brain abeta 1-42 levels. Biochem. Biophys. Res. Commun. 252, 711715.
  • Kuriyama M., Hokezu Y., Togo S., Nagata K., Takahashi K., Igakura T. and Osame M. (1992) Serum lipids, lipoproteins and apolipoproteins in patients with senile dementia. Nippon Ronen Igakkai Zasshi 29, 559564.
  • Kuriyama M., Takahashi K., Yamano T., Hokezu Y., Togo S., Osame M. and Igakura T. (1994) Low levels of serum apolipoprotein A I and A II in senile dementia. Jpn. J. Psychiatry Neurol. 48, 589593.
  • Laakso M. (1993) How good a marker is insulin level for insulin resistance? Am. J. Epidemiol. 137, 959965.
  • Lamarche B. (1998) Abdominal obesity and its metabolic complications: implications for the risk of ischaemic heart disease. Coron. Artery Dis. 9, 473481.
  • Langan S. J., Deary I. J., Hepburn D. A. and Frier B. M. (1991) Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus. Diabetologia 34, 337344.
  • Lau F. C., Shukitt-Hale B. and Joseph J. A. (2007) Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. Subcell. Biochem. 42, 299318.
  • Launer L. J. (2003) Epidemiology of white-matter lesions. Int. Psychogeriatr. 15(Suppl 1), 99103.
  • Lee D. Y., Fletcher E., Martinez O., Ortega M., Zozulya N., Kim J., Tran J., Buonocore M., Carmichael O. and DeCarli C. (2009) Regional pattern of white matter microstructural changes in normal aging, MCI, and AD. Neurology 73, 17221728.
  • Leibson C. L., Rocca W. A., Hanson V. A., Cha R., Kokmen E., O’Brien P. C. and Palumbo P. J. (1997) The risk of dementia among persons with diabetes mellitus: a population-based cohort study. Ann. N Y Acad. Sci. 826, 422427.
  • Leone S., Ottani A. and Bertolini A. (2007) Dual acting anti-inflammatory drugs. Curr. Top. Med. Chem. 7, 265275.
  • Lesser G., Kandiah K., Libow L. S., Likourezos A., Breuer B., Marin D., Mohs R., Haroutunian V. and Neufeld R. (2001) Elevated serum total and LDL cholesterol in very old patients with Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 12, 138145.
  • Li Z. G., Zhang W. and Sima A. A. (2007) Alzheimer-like changes in rat models of spontaneous diabetes. Diabetes 56, 18171824.
  • Lippa A. S., Critchett D. J., Ehlert F., Yamamura H. I., Enna S. J. and Bartus R. T. (1981) Age-related alterations in neurotransmitter receptors: an electrophysiological and biochemical analysis. Neurobiol. Aging 2, 38.
  • Luchsinger J. A., Tang M. X., Shea S. and Mayeux R. (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63, 11871192.
  • MacKnight C., Rockwood K., Awalt E. and McDowell I. (2002) Diabetes mellitus and the risk of dementia, Alzheimer’s disease and vascular cognitive impairment in the Canadian Study of Health and Aging. Dement. Geriatr. Cogn. Disord. 14, 7783.
  • Magnusson K. R. (2000) Declines in mRNA expression of different subunits may account for differential effects of aging on agonist and antagonist binding to the NMDA receptor. J. Neurosci. 20, 16661674.
  • Maier C. M. and Chan P. H. (2002) Role of superoxide dismutases in oxidative damage and neurodegenerative disorders. Neuroscientist 8, 323334.
  • Manev H., Uz T., Sugaya K. and Qu T. (2000) Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J. 14, 14641469.
  • Mantena S. K., King A. L., Andringa K. K., Eccleston H. B. and Bailey S. M. (2008) Mitochondrial dysfunction and oxidative stress in the pathogenesis of alcohol- and obesity-induced fatty liver diseases. Free Radic. Biol. Med. 44, 12591272.
  • Massaad C. A., Washington T. M., Pautler R. G. and Klann E. (2009) Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer’s disease. Proc. Natl Acad. Sci. USA 106, 1357613581.
  • Matia M., Lecumberri P. and Calle P. (2007) Nutrition and metabolic syndrome. Rev. Esp. Salud. Publica. 81, 489505.
  • Matsuzawa-Nagata N., Takamura T., Ando H. et al. (2008) Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 57, 10711077.
  • Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I. and Rydel R. E. (1992) beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12, 376389.
  • Mattson M. P., Barger S. W., Begley J. G. and Mark R. J. (1995a) Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46, 187216.
  • Mattson M. P., Lovell M. A., Furukawa K. and Markesbery W. R. (1995b) Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons. J. Neurochem. 65, 17401751.
  • Mattson M. P., Duan W. and Guo Z. (2003) Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms. J. Neurochem. 84, 417431.
  • McClearn G. E. (1997) Biomarkers of age and aging. Exp. Gerontol. 32, 8794.
  • McNay E. C. and Gold P. E. (2002) Food for thought: fluctuations in brain extracellular glucose provide insight into the mechanisms of memory modulation. Behav. Cogn. Neurosci. Rev. 1, 264280.
  • McNay E. C., Fries T. M. and Gold P. E. (2000) Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task. Proc. Natl Acad. Sci. USA 97, 28812885.
  • Medawar P. B. (1952) An Unsolved Problem of Biology. H.K. Lewis, London.
  • Mendall M. A., Patel P., Ballam L., Strachan D. and Northfield T. C. (1996) C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ 312, 10611065.
  • Meng S. Z., Ozawa Y., Itoh M. and Takashima S. (1999) Developmental and age-related changes of dopamine transporter, and dopamine D1 and D2 receptors in human basal ganglia. Brain Res. 843, 136144.
  • Messier C., Desrochers A. and Gagnon M. (1999) Effect of glucose, glucose regulation, and word imagery value on human memory. Behav. Neurosci. 113, 431438.
  • Michikawa M. (2003) Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer’s disease? J. Neurosci. Res. 72, 141146.
  • Miller E. A. and Allen D. O. (1973) Hormone-stimulated lipolysis in isolated fat cells from “young” and “old” rats. J. Lipid Res. 14, 331336.
  • Miller J. P., Pratley R. E., Goldberg A. P., Gordon P., Rubin M., Treuth M. S., Ryan A. S. and Hurley B. F. (1994) Strength training increases insulin action in healthy 50- to 65-yr-old men. J. Appl. Physiol. 77, 11221127.
  • Milne J. C., Lambert P. D., Schenk S. et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712716.
  • Moller D. E. and Kaufman K. D. (2005) Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56, 4562.
  • Moreira P. I., Nunomura A., Nakamura M., Takeda A., Shenk J. C., Aliev G., Smith M. A. and Perry G. (2008) Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med. 44, 14931505.
  • Morin A. M. and Wasterlain C. G. (1980) Aging and rat brain muscarinic receptors as measured by quinuclidinyl benzilate binding. Neurochem. Res. 5, 301308.
  • Morrison J. H. and Hof P. R. (1997) Life and death of neurons in the aging brain. Science 278, 412419.
  • Muckle T. J. and Roy J. R. (1985) High-density lipoprotein cholesterol in differential diagnosis of senile dementia. Lancet 1, 11911193.
  • Nag S. and Kilty D. W. (1997) Cerebrovascular changes in chronic hypertension. Protective effects of enalapril in rats. Stroke 28, 10281034.
  • Nagai N., Van H. B. and Lijnen H. R. (2007) Plasminogen activator inhibitor-1 contributes to the deleterious effect of obesity on the outcome of thrombotic ischemic stroke in mice. J. Thromb. Haemost. 5, 17261731.
  • Navarro A. and Boveris A. (2008) Mitochondrial nitric oxide synthase, mitochondrial brain dysfunction in aging, and mitochondria-targeted antioxidants. Adv. Drug Deliv. Rev. 60, 15341544.
  • Newton I. G., Forbes M. E., Linville M. C., Pang H., Tucker E. W., Riddle D. R. and Brunso-Bechtold J. K. (2008) Effects of aging and caloric restriction on dentate gyrus synapses and glutamate receptor subunits. Neurobiol. Aging 29, 13081318.
  • Nielsen M. F., Wise S., Dinneen S. F., Schwenk W. F., Basu A. and Rizza R. A. (1997) Assessment of hepatic sensitivity to glucagon in NIDDM: use as a tool to estimate the contribution of the indirect pathway to nocturnal glycogen synthesis. Diabetes 46, 20072016.
  • Nisoli E., Clementi E., Carruba M. O. and Moncada S. (2007) Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ. Res. 100, 795806.
  • Nunomura A., Perry G., Pappolla M. A., Wade R., Hirai K., Chiba S. and Smith M. A. (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. J. Neurosci. 19, 19591964.
  • Nyberg G., Mellgren G. and Smith U. (1976) Human adipose tissue in culture. VI. Effect of age on cell size and lipolysis. Acta Paediatr. Scand. 65, 313318.
  • Oakes N. D., Cooney G. J., Camilleri S., Chisholm D. J. and Kraegen E. W. (1997) Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46, 17681774.
  • Ogawa N. (1989) Central acetylcholinergic systems in the normal aged and in the patient with Alzheimer-type dementia (ATD). Rinsho Shinkeigaku 29, 15291531.
  • Oomura Y., Hori N., Shiraishi T. et al. (2006) Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 27, 27382749.
  • O’Shaughnessy I. M., Kasdorf G. M., Hoffmann R. G. and Kalkhoff R. K. (1992) Does aging intensify the insulin resistance of human obesity? J. Clin. Endocrinol. Metab. 74, 10751081.
  • Osmond J. M., Mintz J. D., Dalton B. and Stepp D. W. (2009) Obesity increases blood pressure, cerebral vascular remodeling, and severity of stroke in the Zucker rat. Hypertension 53, 381386.
  • Ott A., Stolk R. P., van H. F., Pols H. A., Hofman A. and Breteler M. M. (1999) Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53, 19371942.
  • Pacini G., Valerio A., Beccaro F., Nosadini R., Cobelli C. and Crepaldi G. (1988) Insulin sensitivity and beta-cell responsivity are not decreased in elderly subjects with normal OGTT. J. Am. Geriatr. Soc. 36, 317323.
  • Paolisso G., Scheen A. and Lefebvre P. (1995) Glucose handling, diabetes and ageing. Horm. Res. 43, 5257.
  • Park S., Kim Y. W., Kim J. Y., Jang E. C., Doh K. O. and Lee S. K. (2001) Effect of high fat diet on insulin resistance: dietary fat versus visceral fat mass. J. Korean Med. Sci. 16, 386390.
  • Partridge L. and Mangel M. (1999) Messages from mortality: the evolution of death rates in the old. Trends Ecol. Evol. 14, 438442.
  • Pasinetti G. M. and Eberstein J. A. (2008) Metabolic syndrome and the role of dietary lifestyles in Alzheimer’s disease. J. Neurochem. 106, 15031514.
  • Pasinetti G. M., Zhao Z., Qin W. et al. (2007) Caloric intake and Alzheimer’s disease. Experimental approaches and therapeutic implications. Interdiscip. Top. Gerontol. 35, 159175.
  • Patterson P. H. (1995) Cytokines in Alzheimer’s disease and multiple sclerosis. Curr. Opin. Neurobiol. 5, 642646.
  • Pedigo N. W. Jr, Minor L. D. and Krumrei T. N. (1984) Cholinergic drug effects and brain muscarinic receptor binding in aged rats. Neurobiol. Aging 5, 227233.
  • Peila R., Rodriguez B. L. and Launer L. J. (2002) Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes 51, 12561262.
  • Peiris A. N., Mueller R. A., Smith G. A., Struve M. F. and Kissebah A. H. (1986) Splanchnic insulin metabolism in obesity. Influence of body fat distribution. J. Clin. Invest. 78, 16481657.
  • Perlmuter L. C., Nathan D. M., Goldfinger S. H., Russo P. A., Yates J. and Larkin M. (1988) Triglyceride levels affect cognitive function in noninsulin-dependent diabetics. J. Diabet. Complications 2, 210213.
  • Perry G., Castellani R. J., Hirai K. and Smith M. A. (1998) Reactive oxygen species mediate cellular damage in Alzheimer disease. J. Alzheimers Dis. 1, 4555.
  • Perry G., Nunomura A., Raina A. K. et al. (2003) A metabolic basis for Alzheimer disease. Neurochem. Res. 28, 15491552.
  • Petrovitch H., White L. R., Izmirilian G. et al. (2000) Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol. Aging 21, 5762.
  • Pfluger P. T., Herranz D., Velasco-Miguel S., Serrano M. and Tschop M. H. (2008) Sirt1 protects against high-fat diet-induced metabolic damage. Proc. Natl Acad. Sci. USA 105, 97939798.
  • Picard F. and Guarente L. (2005) Molecular links between aging and adipose tissue. Int. J. Obes. (Lond.)(Suppl 1), S36S39.
  • Pinteaux E., Inoue W., Schmidt L., Molina-Holgado F., Rothwell N. J. and Luheshi G. N. (2007) Leptin induces interleukin-1beta release from rat microglial cells through a caspase 1 independent mechanism. J. Neurochem. 102, 826833.
  • Pistell P. J., Morrison C. D., Gupta S., Knight A. G., Keller J. N., Ingram D. K. and Bruce-Keller A. J. (2010) Cognitive impairment following high fat diet consumption is associated with brain inflammation. J. Neuroimmunol. 219, 2532.
  • Qiu C., De R. D. and Fratiglioni L. (2007) The epidemiology of the dementias: an update. Curr. Opin. Psychiatry 20, 380385.
  • Qu T., Uz T. and Manev H. (2000) Inflammatory 5-LOX mRNA and protein are increased in brain of aging rats. Neurobiol. Aging 21, 647652.
  • Rasouli N. and Kern P. A. (2008) Adipocytokines and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 93, S64S73.
  • Razay G., Vreugdenhil A. and Wilcock G. (2007) The metabolic syndrome and Alzheimer disease. Arch. Neurol. 64, 9396.
  • Rinne J. O., Lonnberg P. and Marjamaki P. (1990) Age-dependent decline in human brain dopamine D1 and D2 receptors. Brain Res. 508, 349352.
  • Rizza R. A., Mandarino L. J. and Gerich J. E. (1982a) Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J. Clin. Endocrinol. Metab. 54, 131138.
  • Rizza R. A., Mandarino L. J. and Gerich J. E. (1982b) Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes 31, 663669.
  • Robertson-Tchabo E. A., Arenberg D., Tobin J. D. and Plotz J. B. (1986) A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men. Exp. Gerontol. 21, 459467.
  • Roher A. E., Esh C., Rahman A., Kokjohn T. A. and Beach T. G. (2004) Atherosclerosis of cerebral arteries in Alzheimer disease. Stroke 35, 26232627.
  • Roman G. C. (2004) Age-associated white matter lesions and dementia: are these lesions causal or casual? Arch. Neurol. 61, 15031504.
  • Rosamond W., Flegal K., Furie K. et al. (2008) Heart disease and stroke statistics–2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25e146.
  • Rowe J. W., Minaker K. L., Pallotta J. A. and Flier J. S. (1983) Characterization of the insulin resistance of aging. J. Clin. Invest. 71, 15811587.
  • Sattler R. and Tymianski M. (2000) Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med. 78, 313.
  • Sayre L. M., Zelasko D. A., Harris P. L., Perry G., Salomon R. G. and Smith M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease. J. Neurochem. 68, 20922097.
  • Scacchi R., De B. L., Mantuano E., Vilardo T., Donini L. M., Ruggeri M., Gemma A. T., Pascone R. and Corbo R. M. (1998) DNA polymorphisms of apolipoprotein B and angiotensin I-converting enzyme genes and relationships with lipid levels in Italian patients with vascular dementia or Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 9, 186190.
  • Scheff S. W., DeKosky S. T. and Price D. A. (1990) Quantitative assessment of cortical synaptic density in Alzheimer’s disease. Neurobiol. Aging 11, 2937.
  • Schmitt-Schillig S., Schaffer S., Weber C. C., Eckert G. P. and Muller W. E. (2005) Flavonoids and the aging brain. J. Physiol. Pharmacol. 56(Suppl 1), 2336.
  • Shen X., Zheng S., Thongboonkerd V., Xu M., Pierce W. M. Jr, Klein J. B. and Epstein P. N. (2004) Cardiac mitochondrial damage and biogenesis in a chronic model of type 1 diabetes. Am. J. Physiol. Endocrinol. Metab. 287, E896E905.
  • Shi L., Adams M. M., Linville M. C., Newton I. G., Forbes M. E., Long A. B., Riddle D. R. and Brunso-Bechtold J. K. (2007) Caloric restriction eliminates the aging-related decline in NMDA and AMPA receptor subunits in the rat hippocampus and induces homeostasis. Exp. Neurol. 206, 7079.
  • Shimokata H., Tobin J. D., Muller D. C., Elahi D., Coon P. J. and Andres R. (1989) Studies in the distribution of body fat: I. Effects of age, sex, and obesity. J. Gerontol. 44, M66M73.
  • Smith S. R. and Wilson P. W. (2006) Free fatty acids and atherosclerosis–guilty or innocent? J. Clin. Endocrinol. Metab. 91, 25062508.
  • Smith M. A., Perry G., Richey P. L., Sayre L. M., Anderson V. E., Beal M. F. and Kowall N. (1996) Oxidative damage in Alzheimer’s. Nature 382, 120121.
  • Smith J. S., Brachmann C. B., Celic I. et al. (2000) A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family. Proc. Natl Acad. Sci. USA 97, 66586663.
  • Sohal R. S., Agarwal S. and Sohal B. H. (1995) Oxidative stress and aging in the Mongolian gerbil (Meriones unguiculatus). Mech. Ageing Dev. 81, 1525.
  • Sonntag W. E., Bennett S. A., Khan A. S., Thornton P. L., Xu X., Ingram R. L. and Brunso-Bechtold J. K. (2000) Age and insulin-like growth factor-1 modulate N-methyl-D-aspartate receptor subtype expression in rats. Brain Res. Bull. 51, 331338.
  • Souza C. G., Moreira J. D., Siqueira I. R., Pereira A. G., Rieger D. K., Souza D. O., Souza T. M., Portela L. V. and Perry M. L. (2007) Highly palatable diet consumption increases protein oxidation in rat frontal cortex and anxiety-like behavior. Life Sci. 81, 198203.
  • Spulber S. and Schultzberg M. (2010) Connection between inflammatory processes and transmittor function–modulatory effects of interleukin-1. Prog. Neurobiol. 90, 256262.
  • Stadtman E. R. and Levine R. L. (2000) Protein oxidation. Ann. N Y Acad. Sci. 899, 191208.
  • Stadtman E. R. and Oliver C. N. (1991) Metal-catalyzed oxidation of proteins. Physiological consequences. J. Biol. Chem. 266, 20052008.
  • Steemburgo T., Dall’Alba V., Gross J. L. and Azevedo M. J. (2007) Dietary factors and metabolic syndrome. Arq. Bras. Endocrinol. Metabol. 51, 14251433.
  • Steen E., Terry B. M., Rivera E. J., Cannon J. L., Neely T. R., Tavares R., Xu X. J., Wands J. R. and de la Monte S. M. (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease–is this type 3 diabetes? J. Alzheimers Dis. 7, 6380.
  • Strauss S., Bauer J., Ganter U., Jonas U., Berger M. and Volk B. (1992) Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer’s disease patients. Lab. Invest. 66, 223230.
  • Svedberg J., Bjorntorp P., Smith U. and Lonnroth P. (1990) Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39, 570574.
  • Tanner K. G., Landry J., Sternglanz R. and Denu J. M. (2000) Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc. Natl Acad. Sci. USA 97, 1417814182.
  • Tariot P. N., Ogden M. A., Cox C. and Williams T. F. (1999) Diabetes and dementia in long-term care. J. Am. Geriatr. Soc. 47, 423429.
  • Taylor V. H. and MacQueen G. M. (2007) Cognitive dysfunction associated with metabolic syndrome. Obes. Rev. 8, 409418.
  • Terao A., Apte-Deshpande A., Dousman L., Morairty S., Eynon B. P., Kilduff T. S. and Freund Y. R. (2002) Immune response gene expression increases in the aging murine hippocampus. J. Neuroimmunol. 132, 99112.
  • Terao S., Yilmaz G., Stokes K. Y., Ishikawa M., Kawase T. and Granger D. N. (2008) Inflammatory and injury responses to ischemic stroke in obese mice. Stroke 39, 943950.
  • Terry A. V. Jr and Buccafusco J. J. (2003) The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther. 306, 821827.
  • Tha K. K., Okuma Y., Miyazaki H., Murayama T., Uehara T., Hatakeyama R., Hayashi Y. and Nomura Y. (2000) Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res. 885, 2531.
  • Thiels E. and Klann E. (2002) Hippocampal memory and plasticity in superoxide dismutase mutant mice. Physiol. Behav. 77, 601605.
  • Thiels E., Urban N. N., Gonzalez-Burgos G. R., Kanterewicz B. I., Barrionuevo G., Chu C. T., Oury T. D. and Klann E. (2000) Impairment of long-term potentiation and associative memory in mice that overexpress extracellular superoxide dismutase. J. Neurosci. 20, 76317639.
  • Tohgi H., Abe T., Hashiguchi K., Saheki M. and Takahashi S. (1994) Remarkable reduction in acetylcholine concentration in the cerebrospinal fluid from patients with Alzheimer type dementia. Neurosci. Lett. 177, 139142.
  • de la Torre J. C. (2004) Is Alzheimer’s disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics Lancet Neurol. 3, 184190.
  • Tschop M. and Heiman M. L. (2001) Rodent obesity models: an overview. Exp. Clin. Endocrinol. Diabetes 109, 307319.
  • Urakawa H., Katsuki A., Sumida Y. et al. (2003) Oxidative stress is associated with adiposity and insulin resistance in men. J. Clin. Endocrinol. Metab. 88, 46734676.
  • Uz T., Pesold C., Longone P. and Manev H. (1998) Aging-associated up-regulation of neuronal 5-lipoxygenase expression: putative role in neuronal vulnerability. FASEB J. 12, 439449.
  • Vannucchi M. G. and Pepeu G. (1987) Effect of phosphatidylserine on acetylcholine release and content in cortical slices from aging rats. Neurobiol. Aging 8, 403407.
  • Volkow N. D., Ding Y. S., Fowler J. S., Wang G. J., Logan J., Gatley S. J., Hitzemann R., Smith G., Fields S. D. and Gur R. (1996) Dopamine transporters decrease with age. J. Nucl. Med. 37, 554559.
  • Wahrenberg H., Lonnqvist F. and Arner P. (1989) Mechanisms underlying regional differences in lipolysis in human adipose tissue. J. Clin. Invest. 84, 458467.
  • Wang Y., Chan G. L., Holden J. E. et al. (1998) Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse 30, 5661.
  • Wang J., Liu R., Liu L., Chowdhury R., Barzilai N., Tan J. and Rossetti L. (1999) The effect of leptin on Lep expression is tissue-specific and nutritionally regulated. Nat. Med. 5, 895899.
  • Wang S., Ma A., Song S., Quan Q., Zhao X. and Zheng X. (2008) Fasting serum free fatty acid composition, waist/hip ratio and insulin activity in essential hypertensive patients. Hypertens. Res. 31, 623632.
  • Ward M. A., Carlsson C. M., Trivedi M. A., Sager M. A. and Johnson S. C. (2005) The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol. 5, 23.
  • Wenk G. L. and Barnes C. A. (2000) Regional changes in the hippocampal density of AMPA and NMDA receptors across the lifespan of the rat. Brain Res. 885, 15.
  • White C. L., Pistell P. J., Purpera M. N., Gupta S., Fernandez-Kim S. O., Hise T. L., Keller J. N., Ingram D. K., Morrison C. D. and Bruce-Keller A. J. (2009) Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet. Neurobiol. Dis. 35, 313.
  • Wieringa G. E., Burlinson S., Rafferty J. A., Gowland E. and Burns A. (1997) Apolipoprotein E genotypes and serum lipid levels in Alzheimer’s disease and multi-infarct dementia. Int. J. Geriatr. Psychiatry 12, 359362.
  • Williams B. R., Hultsch D. F., Strauss E. H., Hunter M. A. and Tannock R. (2005) Inconsistency in reaction time across the life span. Neuropsychology 19, 8896.
  • Winocur G. and Greenwood C. E. (2005) Studies of the effects of high fat diets on cognitive function in a rat model. Neurobiol. Aging 26(Suppl 1), 4649.
  • Wong D. F., Wagner H. N. Jr, Dannals R. F., Links J. M., Frost J. J., Ravert H. T., Wilson A. A., Rosenbaum A. E., Gjedde A. and Douglass K. H. (1984) Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 226, 13931396.
  • Woods S. C., Seeley R. J., Rushing P. A., D’Alessio D. and Tso P. (2003) A controlled high-fat diet induces an obese syndrome in rats. J. Nutr. 133, 10811087.
  • Wu C. F., Bertorelli R., Sacconi M., Pepeu G. and Consolo S. (1988) Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol. Aging 9, 357361.
  • Wu A., Ying Z. and Gomez-Pinilla F. (2004) The interplay between oxidative stress and brain-derived neurotrophic factor modulates the outcome of a saturated fat diet on synaptic plasticity and cognition. Eur. J. Neurosci. 19, 16991707.
  • Xiao H. D., Fuchs S., Frenzel K., Teng L. and Bernstein K. E. (2004) Circulating versus local angiotensin II in blood pressure control: lessons from tissue-specific expression of angiotensin-converting enzyme (ACE). Crit. Rev. Eukaryot. Gene Expr. 14, 137145.
  • Yaffe K. (2007) Metabolic syndrome and cognitive disorders: is the sum greater than its parts? Alzheimer Dis. Assoc. Disord. 21, 167171.
  • Yasui F., Ishibashi M., Matsugo S., Kojo S., Oomura Y. and Sasaki K. (2003) Brain lipid hydroperoxide level increases in senescence-accelerated mice at an early age. Neurosci. Lett. 350, 6668.
  • Ye S. M. and Johnson R. W. (1999) Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 93, 139148.
  • Yudkin J. S., Stehouwer C. D., Emeis J. J. and Coppack S. W. (1999) C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19, 972978.
  • Zhang X., Dong F., Ren J., Driscoll M. J. and Culver B. (2005) High dietary fat induces NADPH oxidase-associated oxidative stress and inflammation in rat cerebral cortex. Exp. Neurol. 191, 318325.
  • Zhao W. Q., Chen H., Quon M. J. and Alkon D. L. (2004) Insulin and the insulin receptor in experimental models of learning and memory. Eur. J. Pharmacol. 490, 7181.
  • Zlokovic B. V. (2005) Neurovascular mechanisms of Alzheimer’s neurodegeneration. Trends Neurosci. 28, 202208.